GSA Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$959K Buy
2,459
+1,008
+69% +$426K 0.06% 525
2026
Q1
$687K Buy
+1,451
New +$730K 0.04% 720
2025
Q4
Sell
-2,197
Closed -$936K 1832
2025
Q3
$936K Buy
+2,197
New +$852K 0.08% 442
2025
Q2
Sell
-1,219
Closed -$421K 1904
2025
Q1
$421K Sell
1,219
-2,998
-71% -$964K 0.04% 917
2024
Q4
$1.27M Buy
4,217
+2,823
+203% +$987K 0.09% 254
2024
Q3
$567K Buy
+1,394
New +$510K 0.04% 832
2024
Q1
Sell
-2,678
Closed -$725K 1759
2023
Q4
$725K Sell
2,678
-3,016
-53% -$745K 0.06% 573
2023
Q3
$1.4M Buy
+5,694
New +$1.56M 0.12% 241
2023
Q2
Sell
-1,110
Closed -$293K 1672
2023
Q1
$293K Buy
+1,110
New +$282K 0.03% 1041
2022
Q2
Sell
-1,301
Closed -$326K 1562
2022
Q1
$326K Buy
+1,301
New +$327K 0.04% 834
2021
Q4
Sell
-4,344
Closed -$1.05M 1565
2021
Q3
$1.05M Buy
+4,344
New +$1.06M 0.11% 290
2021
Q2
Sell
-2,167
Closed -$408K 1426
2021
Q1
$408K Buy
+2,167
New +$382K 0.07% 458
2020
Q2
Sell
-6,402
Closed -$575K 817
2020
Q1
$575K Buy
6,402
+2,230
+53% +$289K 0.14% 114
2019
Q4
$617K Sell
4,172
-5,379
-56% -$722K 0.07% 508
2019
Q3
$1.15M Buy
9,551
+3,563
+60% +$460K 0.16% 117
2019
Q2
$809K Sell
5,988
-4,036
-40% -$510K 0.09% 356
2019
Q1
$1.31M Buy
10,024
+2,513
+33% +$338K 0.13% 168
2018
Q4
$935K Buy
7,511
+5,406
+257% +$726K 0.11% 249
2018
Q3
$293K Sell
2,105
-37,447
-95% -$4.66M 0.02% 1334
2018
Q2
$4.06M Buy
39,552
+13,874
+54% +$1.4M 0.2% 58
2018
Q1
$2.49M Buy
+25,678
New +$2.49M 0.13% 183
2017
Q3
Sell
-2,351
Closed -$205K 1721
2017
Q2
$205K Sell
2,351
-33,720
-93% -$2.85M 0.01% 1491
2017
Q1
$3.21M Buy
36,071
+12,742
+55% +$1.06M 0.17% 88
2016
Q4
$1.73M Sell
23,329
-15,465
-40% -$1.16M 0.1% 266
2016
Q3
$2.93M Sell
38,794
-23,756
-38% -$1.82M 0.16% 106
2016
Q2
$4.82M Buy
62,550
+41,312
+195% +$3.26M 0.27% 20
2016
Q1
$1.66M Sell
21,238
-11,836
-36% -$827K 0.11% 270
2015
Q4
$2.24M Sell
33,074
-81,555
-71% -$5.69M 0.11% 213
2015
Q3
$8.87M Buy
114,629
+71,608
+166% +$6.34M 0.44% 14
2015
Q2
$3.9M Sell
43,021
-5,006
-10% -$401K 0.15% 98
2015
Q1
$3.61M Sell
48,027
-11,613
-19% -$834K 0.14% 109
2014
Q4
$4.38M Buy
59,640
+19,624
+49% +$1.38M 0.31% 15
2014
Q3
$2.82M Buy
40,016
+1,153
+3% +$76.2K 0.15% 137
2014
Q2
$2.19M Buy
+38,863
New +$2.05M 0.1% 219
2014
Q1
Sell
-7,098
Closed -$339K 1652
2013
Q4
$339K Sell
7,098
-1,800
-20% -$83.2K 0.03% 1116
2013
Q3
$380K Sell
8,898
-224,454
-96% -$8.77M 0.03% 976
2013
Q2
$8.41M Buy
+233,352
New +$9.03M 1% 1

Other funds holding HCA

GSA Capital Partners's HCA Position: Q2 2026 in Review

GSA Capital Partners increased its HCA Healthcare (HCA) stake by 69% in Q2 2026, buying an estimated $426K and bringing the position to 2,459 shares worth $959K. The position accounts for 0.06% of the portfolio, ranked #525.

GSA Capital Partners first reported a position in HCA in Q2 2013 and has held it in 37 quarters since. The position peaked at $8.87M in Q3 2015. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • GSA Capital Partners held 2,459 shares of HCA Healthcare worth $959K as of Q2 2026.
  • GSA Capital Partners bought 1,008 HCA Healthcare shares in Q2 2026, an estimated $426K.
  • HCA Healthcare made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #525 holding.
  • GSA Capital Partners first reported a position in HCA Healthcare in Q2 2013 and has held it in 37 quarters since.
  • GSA Capital Partners's HCA Healthcare position peaked at $8.87M in Q3 2015.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.